The HELLP syndrome;HELLP-syndromet

Tidsskrift for den Norske Laegeforening

Volumn 120, Issue 12, 2000, Pages 1433-1436

  Haram, Kjell ^a   Bjørge, Line ^a   Guttu, Kristian ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b Kvinneklinikken   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HELLP SYNDROME; HUMAN; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PROGNOSIS; REVIEW;

FEMALE; HELLP SYNDROME; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROGNOSIS;

EID: 0034630619     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142: 159-67.
2. Barton JR, Riely CA, Adamec TA, Shanklin DR, Khoury AD, Sibai BM. Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 1992; 167: 1538-43.
3. Stone JH. HELLP syndrome: hemolysis, elevated liver enzymes, and low platelets. JAMA 1998; 280: 559-62.
4. Geary M. The HELLP syndrome. Br J Obstet Gynaecol 1997; 104: 887-91.
5. Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986; 155: 501-9.
6. Reubinoff BE, Schenker JG. HELLP syndrome - a syndrome of hemolysis, elevated liver enzymes and low platelet count - complicating preeclampsia-eclampsia. Int J Gynaecol Obstet 1991; 36: 95-102.
7. Ellison J, Sattar N, Greer I. HELLP syndrome: mechanisms and management. Hosp Med 1999; 60: 243-9.
8. Kolben M, Lopens A, Schmitt M, Schneider KT, Graeff H. Changes in fibrinolysis-associated parameters in HELLP syndrome. Geburtshilfe Frauenheilkd 1994; 54: 257-61.
9. Brenner B, Lanir N, Thaler I. HELLP syndrome associated with factor V R506Q mutation. Br J Haematol 1996; 92: 999-1001.
10. Krauss T, Augustin HG, Osmers R, Meden H, Unterhalt M, Kuhn W. Activated protein C resistance and factor V Leiden in patients with hemolysis, elevated liver enzymes, low platelets syndrome. Obstet Gynecol 1998; 92: 457-60.
11. Jones SL. HELLP! A cry for laboratory assistance: a comprehensive review of the HELLP syndrome highlighting the role of the laboratory. Hematopathol Mol Hematol 1998; 11: 147-71.
12. Haeger M, Unander M, Andersson B, Tarkowski A, Arnestad JP, Bengtsson A. Increased release of tumor necrosis factor-alpha and interleukin-6 in women with the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Acta Obstet Gynecol Scand 1996; 75: 695-701.
13. Arbogast E, Schafer W, Zahradnik HP. Alterations of intrauterine eicosanoid production in pregnancy-induced hypertension: decreased production of 12-hydroxyeicosatetraenoic acid in the placenta. Prostaglandins 1996; 51: 125-37.
14. Knapen MF, Peters WH, Mulder TP, Merkus HM, Jansen JB, Steegers EA. Glutathione and glutathione-related enzymes in decidua and placenta of controls and women with pre-eclampsia. Placenta 1999; 20: 541-6.
15. Schiff E, Ben-Baruch G, Peleg E, Rosenthal T, Alcalay M, Devir M et al. Immunoreactive circulating endothelin-1 in normal and hypertensive pregnancies. Am J Obstet Gynecol 1992; 166: 624-8.
16. Jones KA, Abramowicz JS, Anissi D, Mirwald MA, Sherer DM. Severe HELLP syndrome presenting with acute gum bleeding following toothbrushing at 38 weeks' gestation. Am J Crit Care 1993; 2: 395-6.
17. Paternoster DM, Stella A, Simioni P, Mussap M, Plebani M. Coagulation and plasma fibronectin parameters in HELLP syndrome. Int J Gynaecol Obstet 1995; 50: 263-8.
18. McMahon LP, O'Coigligh S, Redman CW. Hepatic enzymes and the HELLP syndrome: a long-standing error? Br J Obstet Gynaecol 1993; 100: 693-5.
19. Magann EF, Martin JNJ. Complicated postpartum preeclampsia-eclampsia. Obstet Gynecol Clin North Am 1995; 22: 337-56.
20. Pillai M. Platelets and pregnancy. Br J Obstet Gynaecol 1993; 100: 201-4.
21. Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1996; 175: 460-4.
22. Magann EF, Roberts WE, Perry KGJ, Chauhan SP, Blake PG, Martin JNJ. Factors relevant to mode of preterm delivery with syndrome of HELLP (hemolysis, elevated liver enzymes, and low platelets). Am J Obstet Gynecol 1994; 170: 1828-32.
23. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol 1990; 162: 311-6.
24. Martin JNJ, Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 1999; 180: 1373-84.
25. Abramovici D, Friedman SA, Mercer BM, Audibert F, Kao L, Sibai BM. Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter? Am J Obstet Gynecol 1999; 180: 221-5.
26. Knox TA, Olans LB. Liver disease in pregnancy. N Engl J Med 1996; 335: 569-76.
27. Poldre PA. Haptoglobin helps diagnose the HELLP syndrome. Am J Obstet Gynecol 1987; 157: 1267.
28. Garzetti GG, Tranquilli AL, Cugini AM, Mazzanti L, Cester N, Romanini C. Altered lipid composition, increased lipid peroxidation, and altered fluidity of the membrane as evidence of platelet damage in preeclampsia. Obstet Gynecol 1993; 81: 337-40.
29. Haram K, Augensen K, Elsayed S. Serum protein pattern in normal pregnancy with special reference to acute-phase reactants. Br J Obstet Gynaecol 1983; 90: 139-45.
30. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993; 169: 1000-6.
31. To WW, Lau WN. Transient blindness associated with hypertensive disorders in pregnancy. Aust N Z J Obstet Gynaecol 1995; 35: 363-5.
32. Sibai BM, Ramadan MK, Chari RS, Friedman SA. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol 1995; 172: 125-9.
33. Portis R, Jacobs MA, Skerman JH, Skerman EB. HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) pathophysiology and anesthetic considerations. AANA J 1997; 65: 37-47.
34. Onrust S, Santema JG, Aarnoudse JG. Preeclampsia and the HELLP syndrome still cause maternal mortality in The Netherlands and other developed countries; can we reduce it? Eur J Obstet Gynecol Reprod Biol 1999; 82: 41-6.
35. Catanzarite VA, Steinberg SM, Mosley CA, Landers CF, Cousins LM, Schneider JM. Severe preeclampsia with fulminant and extreme elevation of aspartate aminotransferase and lactate dehydrogenase levels: high risk for maternal death. Am J Perinatol 1995; 12: 310-3.
36. Isler CM, Rinehart BK, Terrone DA, Martin RW, Magann EF, Martin JNJ. Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1999; 181: 924-8.
37. Van Hook JW. Management of complicated preeclampsia. Semin Perinatol 1999; 23: 79-90.
38. Padden MO. HELLP syndrome: recognition and perinatal management. Am Fam Physician 1999; 60: 829-36, 839.
39. Tompkins MJ, Thiagarajah S. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: the benefit of corticosteroids. Am J Obstet Gynecol 1999; 181: 304-9.
40. Tsatsaris V, Carbonne B, Dupre LT, Cabrol D, Milliez J. Is conservative treatment of HELLP syndrome safe? Eur J Obstet Gynecol Reprod Biol 1998; 80: 139-41.
41. Magann EF, Bass D, Chauhan SP, Sullivan DL, Martin RW, Martin JNJ. Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994; 171: 1148-53.
42. Sullivan CA, Magann EF, Perry KGJ, Roberts WE, Blake PG, Martin JNJ. The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations. Am J Obstet Gynecol 1994; 171: 940-3.
43. Martin JNJ, Blake PG, Perry KGJ, McCaul JF, Hess LW, Martin RW. The natural history of HELLP syndrome: patterns of disease progression and regression. Am J Obstet Gynecol 1991; 164: 1500-9.
44. Magann EF, Perry KGJ, Meydrech EF, Harris RL, Chauhan SP, Martin JNJ. Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994; 171: 1154-8.
45. Yalcin OT, Sener T, Hassa H, Ozalp S, Okur A. Effects of postpartum corticosteroids in patients with HELLP syndrome. Int J Gynaecol Obstet 1998; 61: 141-8.
46. van Pampus MG, Dekker GA, Wolf H, Huijgens PC, Koopman MM, von Blomberg BM et al. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol 1999; 180: 1146-50.
47. Riyazi N, Leeda M, de Vries JI, Huijgens PC, van Geijn HP, Dekker GA. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. Eur J Obstet Gynecol Reprod Biol 1998; 80: 49-54.